Critical dissolution tests of oral systems based on statistically designed experiments. II. In vitro optimization of screened variables on ER-coated spheres for the establishment of an in vitro/in vivo correlation

Drug Development and Industrial Pharmacy

Volumn 24, Issue 3, 1998, Pages 203-212

  Abuzarur Aloul, R ^a   Gjellan, K ^a   Sjolund M ^a   Graffner, C ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

REMOXIPRIDE;

ARTICLE; DRUG COATING; DRUG RELEASE; DRUG SOLUBILITY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; OSMOLALITY; STATISTICAL MODEL; TEMPERATURE;

EID: 0031933721     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049809085611     Document Type: Article

References (24)

1. F. I. P. Joint Report of the Section for Official Laboratories and Medicines Control Services and the Section of Industrial Pharmacists of the F.I.P., Guidelines for dissolution testing of oral solid products, Pharmacopeial Forum, 21(5), 1371-1382 (1995).
2. United States Pharmacopeia, 23rd Revision, Mac Publishing Company, Easton, PA, 1995.
3. J. P. Skelly, G. L. Amidon, W. H. Barr, L. Z. Benet, J. E. Carter, J. R. Robinson, V. P. Shah, and A. Yacobi, In vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms, Pharm. Res., 7(9), 975 (1990).
4. J. W. Skoug, G. W. Halstead, D. L. Theis, J. E. Freeman, D. T. Fagan, and B. R. Rohrs, Strategy for the development and validation of dissolution tests for solid oral dosage forms, Pharm. Technol., 58-72 (1996).
5. C. F. Dick, R. A. Klassen, and G. E. Amidon, Determination of the sensitivity of a tablet formulation to variations in excipients levels and processing conditions using optimization techniques, Int. J. Pharm., 38, 23-31 (1987).
6. J. B. Schwartz, J. R. Flamholz, and R. H. Press, Computer optimization of pharmaceutical formulations I: General procedure, J. Pharm. Sci., 62, 1163-1170 (1973).
7. J. Gottfries, J. Ahlbom, V. Harang, E. Johansson, M. Josefson, T. Morsing, A. Pettersson, and A. Torstensson, Validation of an extended release tablet dissolution testing system using design and multivariate analysis, Int. J. Pharm., 106, 141-148 (1994).
8. T. Østberg and C. Graffner, Calcium alginate matrices for oral multiple unit administration: III. Influence of calcium concentration, amount of drug added and alginate characteristics on drug release. Int. J. Pharm., 111, 271-282 (1994).
9. P. J. Waaler, M. Andersen, C. Graffner, and B. W. Müller, Influence of compaction pressure on the properties of xanthan/guar gum matrix tablets, Acta Pharm. Nordica, 4, 167-170 (1992).
10. 4 factoral design. Drug. Dev. Ind. Pharm., 22, 7, 623-630 (1996).
11. S. Bouckaert, D. L. Massart, B. Massart, and J. P. Remon, Optimization of a granulation procedure for a hydrophilic matrix tablet using experimental design, Drug. Dev. Ind. Pharm., 22, 4, 322-327 (1996).
12. R. Abuzarur-Aloul, K. Gjellan, M. Sjölund, M. Löfqvist, and C. Graffner, Critical dissolution tests of oral systems based on statistically designed experiments. I. Screening of critical fluids and in vitro/in vivo modelling of extended release coated spheres, Drug. Dev. Ind. Pharm., 23(8), 749-760 (1997).
13. M. Nicklasson, C. Graffner, L. Nilsson, M.-I. Nilsson, and A. Whalén, Absorption properties of the new potential antipsychotic drug remoxipride after oral administration to healthy volunteers, Pharm. Ind., 47(9), 986-990 (1985).
14. G. E. P. Box, W. G. Hunter, and J. S. Hunter, Statistics For Experimenters, Wiley, New York, 1978.
15. A. Höskuldsson, PLS-regression methods, J. Chemom., 2, 211-228 (1988).
16. C. Graffner, M. Särkelä, K. Gjellan, and G. Nork, Use of statistical experimental design in the further development of a discriminating in vitro release test for ethylcellulose ER-coated spheres of remoxipride, Eur. J. Pharm. Sci., 4, 73-83 (1996).
17. F. Langenbucher, Numerical convolution/deconvolution as a tool for correlating in vitro with in vivo drug availability, Pharm. Ind., 44, 1166-1171 (1982).
18. J. G. Wagner and E. Nelson, Percent absorbed time plots derived from blood level and/or urinary excretion data, J. Pharm. Sci., 52, 610-611 (1963).
19. B. Lindstedt, G. Ragnarsson, and J. Hjärtstam, Osmotic pumping as a release mechanism for membrane-coated drug formulations, Int. J. Pharm., 56, 261-268 (1989).
20. G. Ragnarsson, A. Sandberg, M. O. Johansson, B. Lindstedt, and J. Sjögren, In vitro release characteristics of a membrane-coated pellet formulation - influence of drug solubility and particle size, Int. J. Pharm., 79, 223-232 (1992).
21. A. G. Ozturk, S. S. Ozturk, B. O. Palsson, T. A. Wheatley, and J. B. Dressman, Mechanism of release from pellets coated with an ethylcellulose-based film, J. Controlled Release, 14, 203-213 (1990).
22. N. Katori, N. Aoyagi, and T. Terao, Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation, Pharm. Res., 12, 2 (1995).
23. T. T. Karali. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals, Biopharm. Drug Dispos., 16, 351-380 (1995).
24. J. B. Dressman, Methods for assessing drug absorption. 1. Physiologically based dissolution tests. A satellite of the Sixth European Congress on Biopharmaceutics and Pharmacokinetics, April 21, Athens, 1996.